These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31503425)

  • 21. Drug repurposing based on differentially expressed genes suggests drug combinations with possible synergistic effects in treatment of lung adenocarcinoma.
    Yesharim L; Teimourian S
    Cancer Biol Ther; 2023 Dec; 24(1):2253586. PubMed ID: 37710391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
    Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
    Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.
    Mullen DJ; Yan C; Kang DS; Zhou B; Borok Z; Marconett CN; Farnham PJ; Offringa IA; Rhie SK
    PLoS Genet; 2020 Sep; 16(9):e1009023. PubMed ID: 32925947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A global view of regulatory networks in lung cancer: An approach to understand homogeneity and heterogeneity.
    Lu J; Wang W; Xu M; Li Y; Chen C; Wang X
    Semin Cancer Biol; 2017 Feb; 42():31-38. PubMed ID: 27894849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer.
    Kong C; Yao YX; Bing ZT; Guo BH; Huang L; Huang ZG; Lai YC
    PLoS Comput Biol; 2020 May; 16(5):e1007793. PubMed ID: 32428028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.
    Yang X; Huang WT; Wu HY; He RQ; Ma J; Liu AG; Chen G
    Oncol Rep; 2019 Apr; 41(4):2241-2253. PubMed ID: 30816547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma.
    Xiao J; Liu A; Lu X; Chen X; Li W; He S; He B; Chen Q
    Sci Rep; 2017 May; 7(1):2027. PubMed ID: 28515486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies.
    Paudel KR; Singh M; De Rubis G; Kumbhar P; Mehndiratta S; Kokkinis S; El-Sherkawi T; Gupta G; Singh SK; Malik MZ; Mohammed Y; Oliver BG; Disouza J; Patravale V; Hansbro PM; Dua K
    Life Sci; 2024 Sep; 352():122859. PubMed ID: 38925223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Search for Master Regulators in Walking Cancer Pathways.
    Kel AE
    Methods Mol Biol; 2017; 1613():161-191. PubMed ID: 28849562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Biomarker and Co-Regulatory Motifs in Lung Adenocarcinoma Based on Differential Interactions.
    Zhao N; Liu Y; Chang Z; Li K; Zhang R; Zhou Y; Qiu F; Han X; Xu Y
    PLoS One; 2015; 10(9):e0139165. PubMed ID: 26402252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma.
    Shao B; Bjaanæs MM; Helland Å; Schütte C; Conrad T
    PLoS One; 2019; 14(1):e0204186. PubMed ID: 30703089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
    Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
    PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis.
    Song Y; Chen QT; He QQ
    J Cell Biochem; 2019 Sep; 120(9):15443-15454. PubMed ID: 31037767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation.
    Liu L; Ni J; He X
    Dis Markers; 2018; 2018():5736716. PubMed ID: 30154938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferation genes in lung development associated with the prognosis of lung adenocarcinoma but not squamous cell carcinoma.
    Li P; Zhang L; Yu X; Tong R; Di X; Mao Y; Gao Y; Zhang K; Feng L; Cheng S
    Cancer Sci; 2018 Feb; 109(2):308-316. PubMed ID: 29168602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis.
    Ludovini V; Bianconi F; Siggillino A; Piobbico D; Vannucci J; Metro G; Chiari R; Bellezza G; Puma F; Della Fazia MA; Servillo G; Crinò L
    Oncotarget; 2016 May; 7(21):30561-74. PubMed ID: 27081700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
    Rajamani D; Bhasin MK
    Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A co-expressed gene status of adenylate kinase 1/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma.
    Jan YH; Lai TC; Yang CJ; Huang MS; Hsiao M
    Sci Rep; 2019 Aug; 9(1):12329. PubMed ID: 31444368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.